TrialBMJ open2017

Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial.

Shunsuke Furuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.